arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Cencora, Inc.

COR
$309.86 ▼ -2.41 (-0.77%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
20 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
62
Health
Fair
Neutral
auto_awesome

Analytical Summary

Cencora, Inc. shows mixed fundamentals. However, watch Debt to Equity which shows concerning trends. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $60.1B
Dividend Yield 0.71%
Revenue Growth 9.3% ↘
Op. Margin 0.8% ↗
ROIC 19.9% ↘
FCF / Share $16.55 ↗
Trailing P/E 38.6x
Price / Book 39.9x
FCF Yield 5.3%
Debt / Equity 5.08
info Valuation on last close. End-of-day price, Sep 24, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$321.33B
↑ +9.3% —
Net Income Profit after all expenses
$1.55B
↑ +3.0% —
Operating Margin Operating profit as % of sales
0.8%
↑ +10.5% 30th
FCF / Share Free cash flow per share
$16.55
↑ +9.6% —
Long-Term Debt Long-term obligations
$7.66B
↑ +74.6% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↓
31
Returns ↑
99
Financial Health ↓
42
Cash Quality ↑
87

Dividend History

Dividend / share · sourced from SEC filings
$2.20 Latest / share
+7.8% YoY
+8.0% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 20 years · 75 quarters